Study of CYR-064 Versus Placebo in Patients.

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

September 26, 2023

Primary Completion Date

September 30, 2025

Study Completion Date

October 31, 2025

Conditions
Hyposmia
Interventions
COMBINATION_PRODUCT

CYR-064

CYR-064 is a nasal solution.

Trial Locations (14)

18017

Specialty Physician Associates, Bethlehem

21204

Centers for Advanced ENT, Baltimore

29406

Charleston ENT and Allergy, North Charleston

29425

Medical University of South Carolina-MUSC, Charleston

33324

ENTAAFL, Plantation

33487

ENTAAFL, Boca Raton

34952

ENTAAFL, Port Saint Lucie

40220

Advanced ENT and Allergy, Louisville

60612

Rush University Medical Center, Chicago

70072

Tandem Clinical Research, Marrero

77030

Houston Methodist, Houston

80923

Colorado ENT & Allergy, Colorado Springs

98374

Ear Nose Throat & Allergy Associates, Puyallup

66160-8500

KU Medical Center-University of Kansas, Kansas City

Sponsors
All Listed Sponsors
lead

Cyrano Therapeutics, Inc.

INDUSTRY

NCT06019000 - Study of CYR-064 Versus Placebo in Patients. | Biotech Hunter | Biotech Hunter